MINERALS TECHNOLOGIES INC. (MTX) Spending and interest coverage
- R&D / revenue · 12 months: Value 1.09%; Formula and calculation Research and development expense / revenue. Period ending 2026-07-05..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-07-05..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-07-05; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 1.09% | Research and development expense / revenue. Period ending 2026-07-05. $23.40M ÷ $2.15B × 100 ≈ 1.09% |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-07-05. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 23.40M USD | Research and Development Expense |
| Revenue | 2.15B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | (m) | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -28.70M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-05 | $23.40M | $2.15B | (m) | $-28.70M | (m) | 1.09% | (m) | (m) | (m) |
| 2026-04-05 | $23.20M | $2.13B | (m) | $266.20M | (m) | 1.09% | (m) | (m) | (m) |
| 2025-12-31 | $22.90M | $2.07B | $11.90M | $47.40M | (m) | 1.10% | 0.57% | (m) | (m) |
| 2025-09-28 | $22.80M | $2.07B | (m) | $69.50M | (m) | 1.10% | (m) | (m) | (m) |
| 2025-06-29 | $23.10M | $2.06B | (m) | $75.20M | (m) | 1.12% | (m) | (m) | (m) |
| 2025-03-30 | $23.20M | $2.08B | (m) | $51.20M | (m) | 1.12% | (m) | (m) | (m) |
| 2024-12-31 | $23.00M | $2.12B | $11.80M | $286.50M | (m) | 1.09% | 0.56% | (m) | (m) |
| 2024-09-29 | $22.40M | $2.12B | (m) | $269.20M | (m) | 1.05% | (m) | (m) | (m) |
| 2024-06-30 | $21.70M | $2.15B | (m) | $184.70M | (m) | 1.01% | (m) | (m) | (m) |
| 2024-03-31 | $21.50M | $2.16B | (m) | $184.00M | $59.90M | 1.00% | (m) | 3.07× | Reported |
| 2023-12-31 | $21.20M | $2.17B | $11.30M | $171.80M | $59.20M | 0.98% | 0.52% | 2.90× | Reported |
| 2023-10-01 | $21.30M | $2.15B | (m) | $148.60M | $56.70M | 0.99% | (m) | 2.62× | Reported |
| 2023-07-02 | $21.20M | $2.15B | (m) | $192.10M | $52.40M | 0.99% | (m) | 3.67× | Reported |
| 2023-04-02 | $20.60M | $2.15B | (m) | $211.60M | $48.30M | 0.96% | (m) | 4.38× | Reported |
| 2022-12-31 | $20.40M | $2.13B | $10.40M | $214.80M | $43.90M | 0.96% | 0.49% | 4.89× | Reported |
| 2022-10-02 | $20.20M | $2.09B | (m) | $223.80M | $40.20M | 0.96% | (m) | 5.57× | Reported |
| 2022-07-03 | $19.70M | $2.03B | (m) | $248.80M | $38.40M | 0.97% | (m) | 6.48× | Reported |
| 2022-04-03 | $19.60M | $1.92B | (m) | $243.10M | $37.10M | 1.02% | (m) | 6.55× | Reported |
| 2021-12-31 | $19.50M | $1.86B | $10.70M | $235.70M | $37.20M | 1.05% | 0.58% | 6.34× | Reported |
| 2021-10-03 | $19.40M | $1.81B | (m) | $237.60M | $38.90M | 1.07% | (m) | 6.11× | Reported |
| 2021-07-04 | $19.60M | $1.73B | (m) | $225.50M | $39.80M | 1.13% | (m) | 5.67× | Reported |
| 2021-04-04 | $19.80M | $1.63B | (m) | $189.00M | $38.80M | 1.21% | (m) | 4.87× | Reported |
| 2020-12-31 | $19.90M | $1.59B | $10.20M | $187.90M | $38.20M | 1.25% | 0.64% | 4.92× | Reported |
| 2020-09-27 | $20.40M | $1.60B | (m) | $181.10M | $37.40M | 1.27% | (m) | 4.84× | Reported |
| 2020-06-28 | $20.80M | $1.66B | (m) | $186.10M | $38.30M | 1.25% | (m) | 4.86× | Reported |
| 2020-03-29 | $20.60M | $1.77B | (m) | $204.40M | $41.10M | 1.16% | (m) | 4.97× | Reported |
| 2019-12-31 | $20.30M | $1.79B | $8.10M | $208.70M | $43.20M | 1.13% | 0.45% | 4.83× | Reported |
| 2019-09-29 | $20.10M | $1.80B | (m) | $223.30M | $45.30M | 1.12% | (m) | 4.93× | Reported |
| 2019-06-30 | $19.90M | $1.81B | (m) | $238.00M | $46.00M | 1.10% | (m) | 5.17× | Reported |
| 2019-03-31 | $21.40M | $1.81B | (m) | $255.30M | $46.60M | 1.18% | (m) | 5.48× | Reported |
| 2018-12-31 | $22.70M | $1.81B | $6.20M | $255.90M | $45.90M | 1.26% | 0.34% | 5.58× | Reported |
| 2018-09-30 | $23.40M | $1.79B | (m) | $238.00M | $44.80M | 1.31% | (m) | 5.31× | Reported |
| 2018-07-01 | $24.30M | $1.75B | (m) | $237.00M | $43.60M | 1.39% | (m) | 5.44× | Reported |
| 2018-04-01 | $24.00M | $1.70B | (m) | $243.20M | $42.30M | 1.41% | (m) | 5.75× | Reported |
| 2017-12-31 | $23.70M | $1.68B | $8.10M | $242.70M | $43.40M | 1.41% | 0.48% | 5.59× | Reported |
| 2017-10-01 | $23.70M | $1.64B | (m) | $253.50M | $45.50M | 1.44% | (m) | 5.57× | Reported |
| 2017-07-02 | $23.70M | $1.62B | (m) | $254.00M | $48.40M | 1.46% | (m) | 5.25× | Reported |
| 2017-04-02 | $23.70M | $1.63B | (m) | $225.00M | $52.10M | 1.45% | (m) | 4.32× | Reported |
| 2016-12-31 | $23.80M | $1.64B | $6.30M | $220.90M | $54.40M | 1.45% | 0.38% | 4.06× | Reported |
| 2016-10-02 | $23.70M | $1.67B | (m) | $202.10M | $56.80M | 1.42% | (m) | 3.56× | Reported |
| 2016-07-03 | $23.90M | $1.72B | (m) | $184.70M | $57.70M | 1.39% | (m) | 3.20× | Reported |
| 2016-04-03 | $23.60M | $1.75B | (m) | $198.00M | $59.60M | 1.35% | (m) | 3.32× | Reported |
| 2015-12-31 | $23.60M | $1.80B | $11.20M | $200.30M | $60.90M | 1.31% | 0.62% | 3.29× | Reported |
| 2015-09-27 | $24.20M | $1.88B | (m) | $205.20M | $62.10M | 1.28% | (m) | 3.30× | Reported |
| 2015-06-28 | $24.70M | $1.98B | (m) | $222.10M | $63.90M | 1.25% | (m) | 3.48× | Reported |
| 2015-03-29 | $25.20M | $1.93B | (m) | $205.10M | $57.10M | 1.30% | (m) | 3.59× | Reported |
| 2014-12-31 | $24.40M | $1.73B | $5.90M | $168.80M | $41.80M | 1.41% | 0.34% | 4.04× | Reported |
| 2014-09-28 | $23.15M | $1.47B | (m) | $159.65M | $27.96M | 1.58% | (m) | 5.71× | Reported |
| 2014-06-29 | $21.85M | $1.18B | (m) | $125.65M | $12.06M | 1.86% | (m) | 10.42× | Reported |
| 2014-03-30 | $20.33M | $1.01B | (m) | $122.18M | $3.26M | 2.01% | (m) | 37.44× | Reported |
| 2013-12-31 | $20.05M | $1.02B | $5.25M | $126.85M | $3.26M | 1.97% | 0.52% | 38.88× | Reported |
| 2013-09-30 | (m) | $1.00B | (m) | $120.40M | (m) | (m) | (m) | (m) | (m) |
| 2013-09-29 | $19.94M | $1.01B | (m) | $116.83M | $3.02M | 1.97% | (m) | 38.67× | Reported |
| 2013-06-30 | $19.74M | $1.01B | (m) | $112.64M | $3.22M | 1.96% | (m) | 34.97× | Reported |
| 2013-03-31 | $19.94M | $999.77M | (m) | $110.19M | $3.22M | 1.99% | (m) | 34.21× | Reported |
| 2012-12-31 | $20.17M | $1.01B | $5.48M | $110.04M | $3.22M | 2.01% | 0.54% | 34.16× | Reported |
| 2012-09-30 | $20.02M | $1.01B | (m) | $109.48M | $3.25M | 1.98% | (m) | 33.64× | Reported |
| 2012-07-01 | $19.64M | $1.03B | (m) | $107.03M | $3.25M | 1.92% | (m) | 32.89× | Reported |
| 2012-06-30 | (m) | $1.02B | (m) | $108.60M | (m) | (m) | (m) | (m) | (m) |
| 2012-04-01 | $19.51M | $1.04B | (m) | $102.62M | $3.25M | 1.88% | (m) | 31.54× | Reported |
| 2012-03-31 | (m) | $1.02B | (m) | $107.26M | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $19.33M | $1.04B | $7.24M | $100.34M | $3.25M | 1.85% | 0.69% | 30.84× | Reported |
| 2011-10-02 | $19.38M | $1.04B | (m) | $97.93M | $3.34M | 1.87% | (m) | 29.36× | Reported |
| 2011-07-03 | $19.29M | $1.02B | (m) | $97.49M | $3.24M | 1.88% | (m) | 30.13× | Reported |
| 2011-04-03 | $19.32M | $1.01B | (m) | $99.94M | (m) | 1.91% | (m) | (m) | (m) |
| 2010-12-31 | $19.58M | $1.00B | $5.86M | $98.28M | $3.34M | 1.95% | 0.58% | 29.46× | Reported |
| 2010-10-03 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-07-04 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-04-04 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $19.94M | $907.32M | $5.78M | $-17.05M | $3.49M | 2.20% | 0.64% | -4.89× | Reported |
| 2009-09-27 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $23.05M | $1.11B | $4.95M | $81.99M | $5.18M | 2.07% | 0.45% | 15.83× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KRONOS WORLDWIDE INC (KRO) | United States | $0.932B | |
| LSB INDUSTRIES, INC. (LXU) | United States | $0.727B | 21.14 |
| Tronox Holdings plc (TROX) | United States | $0.642B | -1.83 |
| VALHI INC /DE/ (VHI) | United States | $0.466B | -8.09 |
| LUXFER HOLDINGS PLC (LXFR) | $0.461B | 61.95 | |
| NLI HOLDINGS, INC. (NL) | United States | $0.344B | -11.42 |
| LIGHTBRIDGE Corp (LTBR) | United States | $0.252B | -14.06 |
| Air Products & Chemicals, Inc. (APD) | United States | $63.363B | -1,379.33 |
| LINDE PLC (LIN) | United Kingdom | $215.789B | 33.02 |